Sign In
Buy EVFM
$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026
Evofem stock rallies as FDA approves birth-control gel
08:37pm, Friday, 22'nd May 2020
Evofem Biosciences Inc. stock rallied in the extended session Friday after the biotech company said the Food and Drug Administration approved its birth-control gel. Evofem shares surged 23% after hou
Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the
US regulators approve new type of contraceptive gel
07:40pm, Friday, 22'nd May 2020
U.S. regulators on Friday approved a birth control gel that works in a new way to prevent pregnancy
FDA approves new women's non-hormonal gel birth control
06:04pm, Friday, 22'nd May 2020
Phexxi, a non-hormonal gel contraceptive created by Evofem Biosciences, comes in an applicator that women insert up to an hour before sex. A doctor says it 'serves a true unmet need.'
Birth Control Gel Approved as First No-Hormone Option in Decades
05:09pm, Friday, 22'nd May 2020
(Bloomberg) -- A new birth control gel is the first non-hormonal contraceptive to win FDA approval in decades, bringing another option to the $5.4 billion market.The gel, marketed as Phexxi by Evofem
Evofem's gel first non-hormonal contraceptive to get approval in over 30 years
05:07pm, Friday, 22'nd May 2020
The company said earlier in May it was looking to price the contraceptive gel, Phexxi, between $250 and $275 for a box of 12 packs. The gel is a rare new addition to the $5.5 billion U.S. contracepti
PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders
08:05pm, Thursday, 21'st May 2020
PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that it has completed its previously announced distribution of all of the Company's 13,333,334 shares of common stock of Evofem Bi
PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL Stockholders
08:05pm, Monday, 18'th May 2020
PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the final distribution ratio for the previously announced distribution of all of the Company's 13,333,334 shares of common stock o
Evofem Biosciences to Participate in Virtual Fireside Chat at RBC Capital Markets Global Healthcare Conference
12:00pm, Wednesday, 13'th May 2020
Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that it will participate in the upcoming 2020 RBC Capital Markets Global Healthcare Conference.
Chiefs among centerpieces of NFL slate as they chase repeat
05:16pm, Sunday, 10'th May 2020
KANSAS CITY, Mo. (AP) — In the makeshift interview room just outside Hard Rock Stadium in Miami, defensive tackle Chris Jones yelled across to Chiefs teammate Frank Clark, vowing that the Super...
PDL Biopharma Inc (PDLI) Q1 2020 Earnings Call Transcript
01:00pm, Friday, 08'th May 2020
Please note that a slide presentation to accompany management's prepared remarks is available on the Investor Relations section of the PDL website at pdl.com. Joining me today from PDL are Dominique
PDL BioPharma's (PDLI) CEO Dominique Monnet on Q1 2020 Results - Earnings Call Transcript
07:47am, Friday, 08'th May 2020
PDL BioPharma, Inc. (NASDAQ:PDLI) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Jody Cain – LHA Investor Relations Dominique Monn
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
Evofem Biosciences, Inc. (EVFM) Q1 2020 Earnings Call Transcript
11:30am, Thursday, 07'th May 2020
Image source: The Motley Fool. Evofem Biosciences, Inc. (NASDAQ: EVFM)Q1 2020 Earnings CallMay 6, 2020, 11:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Re
Evofem Biosciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
12:00pm, Wednesday, 06'th May 2020
Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today reported financial results for the three-month period ended March 31, 2020.
